ACAD
32.46
+0.08
+0.25%
AEMD
5.7
-0.28
-4.68%
APRI
0.4
+0.02
+5.1316%
ARNA
1.71
-0.04
-2.29%
ATEC
0.35
+0.005
+1.4778%
CNAT
2.06
-0.1
-4.63%
CRXM
0.155
-0.002
-1.022%
CYTX
2.09
0.00
0.00%
DXCM
79.33
+0.33
+0.42%
GNMK
8.7
+0.03
+0.35%
HALO
8.63
+0.2
+2.37%
ILMN
140.38
+2.8
+2.04%
INNV
0.21
-0.01
-3.23%
INO
9.24
-0.19
-2.01%
ISCO
1.98
-0.02
-1.00%
ISIS
57.56
0.00
0.00%
LGND
119.27
-2.15
-1.77%
LPTN
2.18
-0.02
-0.91%
MBVX
0.55
0.00
0.00%
MEIP
1.36
+0.01
+0.74%
MNOV
7.55
+0.21
+2.86%
MRTX
5.46
-0.03
-0.55%
MSTX
0.47
+0.01
+2.17%
NBIX
45.45
+0.06
+0.13%
NUVA
59.72
+0.45
+0.76%
ONCS
1.64
-0.04
-2.38%
ONVO
3.72
+0.08
+2.20%
OREX
0.43
-0.01
-2.54%
OTIC
15.88
+0.13
+0.83%
QDEL
17.86
+0.22
+1.25%
RCPT
231.96
0.00
0.00%
RGLS
2.89
+0.02
+0.70%
RMD
63.23
+1.2
+1.93%
SPHS
2.15
+0.15
+7.50%
SRNE
5.6
-0.35
-5.88%
TROV
4.53
0.00
0.00%
VICL
4.53
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
8.05
-0.04
-0.49%
ACAD
32.46
+0.08
+0.25%
AEMD
5.7
-0.28
-4.68%
APRI
0.4
+0.02
+5.1316%
ARNA
1.71
-0.04
-2.29%
ATEC
0.35
+0.005
+1.4778%
CNAT
2.06
-0.1
-4.63%
CRXM
0.155
-0.002
-1.022%
CYTX
2.09
0.00
0.00%
DXCM
79.33
+0.33
+0.42%
GNMK
8.7
+0.03
+0.35%
HALO
8.63
+0.2
+2.37%
ILMN
140.38
+2.8
+2.04%
INNV
0.21
-0.01
-3.23%
INO
9.24
-0.19
-2.01%
ISCO
1.98
-0.02
-1.00%
ISIS
57.56
0.00
0.00%
LGND
119.27
-2.15
-1.77%
LPTN
2.18
-0.02
-0.91%
MBVX
0.55
0.00
0.00%
MEIP
1.36
+0.01
+0.74%
MNOV
7.55
+0.21
+2.86%
MRTX
5.46
-0.03
-0.55%
MSTX
0.47
+0.01
+2.17%
NBIX
45.45
+0.06
+0.13%
NUVA
59.72
+0.45
+0.76%
ONCS
1.64
-0.04
-2.38%
ONVO
3.72
+0.08
+2.20%
OREX
0.43
-0.01
-2.54%
OTIC
15.88
+0.13
+0.83%
QDEL
17.86
+0.22
+1.25%
RCPT
231.96
0.00
0.00%
RGLS
2.89
+0.02
+0.70%
RMD
63.23
+1.2
+1.93%
SPHS
2.15
+0.15
+7.50%
SRNE
5.6
-0.35
-5.88%
TROV
4.53
0.00
0.00%
VICL
4.53
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
8.05
-0.04
-0.49%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …